Published in Women's Health Weekly, August 24th, 2000
Antagonists against these receptors could be used in treating ovarian cancer, they report in the journal Regulatory Peptides.
B.D. Sun et al. studied three receptors for growth factors known as bombesin/gastrin releasing peptides (GRP) in ovarian tumor specimens and ovarian cancer cells in culture.
"Bombesin-like peptides can function as autocrine or paracrine growth factors and stimulate the growth of various cancers," Sun et al....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly